Duchenne Muscular DystrophyNCT05661071
Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions
An observational study of Duchenne Muscular Dystrophy, run by Hacettepe University at 1 site in Turkey (Türkiye).
Trial summary
This study was planned to determine neuropsychological profiles of children with Duchenne Muscular Dystrophy and investigation of its effects on motor functions \& compare to typically developed peers. Read more about this study
- Who is it for?
- Ages 7 to 16 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Duchenne Muscular Dystrophy
- What is being tested?
- Modified Mini Mental Test:, The Central Nervous System Vital Signs and Conners' Parent Rating Scale-48 (Parent Report)
- Type of treatment
- Pill or oral medicine
- How many people
- 74 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 11 May 2022to 1 Mar 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 16 years
- Men only
- Healthy volunteers accepted
- Child
Study population: Children with Duchenne Muscular Dystrophy
Who may be able to join
- Having been diagnosed with DMD by a pediatric neurologist,
- Being between the ages of 7-16,
- Not to have any diagnosed chronic disease,
- Not having lost yet the ability to write and draw as required by neuropsychological assessments,
- Cooperate with the physiotherapist and be able to comply with their instructions.
Who cannot join
- Inability to cooperate adequately with the physiotherapist who made the evaluations,
- Have had any injury and/or surgery to the lower/upper extremities in the last 6 months, which may prevent the performance of motor function tests.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Pediatric Neuromuscular Diseases Unit for physiotherapy and rehabilitation
Ankara, 06100
About this study
Official title: Determination of Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Investigation of Its Effects on Motor Functions
This study was planned to determine neuropsychological profiles of children with Duchenne Muscular Dystrophy and investigation of its effects on motor functions \& compare to typically developed peers.
Read the detailed description
In this thesis, it is aimed to determine the neuropsychological profiles of children with Duchenne Muscular Dystrophy (DMD) and to investigate its effects on motor functions. The study will be carried out with children between the ages of 7 and 16 who have been diagnosed with DMD as a result of genetic testing and who applied to Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Pediatric Neuromuscular Diseases Unit for physiotherapy and rehabilitation evaluation. In addition, considering the primary purpose of the study, typically developed boys between the ages of 7 and 16 with similar physical characteristics will be included in the study and compared with children with DMD. Typically developed boys included in the study will be evaluated only with neuropsychological tests. Evaluating cognitive function from neuropsychological tests; Modified Mini Mental Test, The Controlled Oral Word Association Test,computer-based The Central Nervous System Vital Signs will be applied. To evaluate neurodevelopmental status from neuropsychological tests; Conners' Parent Rating Scale, Child Behavior Checklist, Strengths and Difficulties Questionnaire (SDQ) will be applied. To evaluate the motor functions of individuals with DMD; Brooke Lower Extremity Functional Classification, Motor Function Measurement, Four Square Step Test, Six Minutes Walk Test, Timed Performance Tests (10 meters Walk/Run Test, Gower's (from a supine to a standing position), Right/Left Leg Standing, Ascent/Descent of 4 Steps) will be used. In the study, in which the effect of the mutation region of dystrophin protein isoforms causing DMD on the neuropsychological profile of children will be investigated by comparing them with typically developed boys and the effect of this on motor function will be examined, the statistical significance level will be considered as p<0.05
- Conditions
- Duchenne Muscular Dystrophy
- Being tested
- Modified Mini Mental Test:, The Controlled Oral Word Association Test, The Central Nervous System Vital Signs, Conners' Parent Rating Scale-48 (Parent Report), Child Behavior Checklist 6-18 ages (Parent Report)
- Keywords
- Duchenne Muscular Dystrophy (DMD), neuropsychological profile, cognitive status, neurodevelopmental status, motor function, balance
- Medical subject headings
- Muscular Dystrophy, Duchenne
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modified Mini Mental Test:Other
To assess the cognitive function of children
The Controlled Oral Word Association TestOther
To assess the cognitive function of children
The Central Nervous System Vital SignsOther
To assess the cognitive function of children
Conners' Parent Rating Scale-48 (Parent Report)Other
To assess attention-deficit/hyperactivity disorder
Child Behavior Checklist 6-18 ages (Parent Report)Other
To assesses both child adaptive behaviors and problem behaviors.
Strengths and Difficulties Questionnaire (Self-Reported)Other
It is a brief emotional and behavioural screening questionnaire for children and young people.
Brooke Lower Extremity Functional ClassificationOther
To determine the functional status of the lower extremity
Motor Function Measurement-32 ItemsOther
To assessment of motor function and progression of weakness in neuromuscular disorders
Four Square Step TestOther
A test of dynamic balance and coordination that clinically assesses the participant's ability to step over objects forward, sideways, and backwards.
Six Minutes Walk TestOther
It evaluates the walking function and physical capacity of children at the submaximal level.
Timed Performance TestOther
10 meters Walk\& Run Test, Gower's(from a supine to a standing position), Right\& Left Leg Standing, Ascent/Descent of 4 Steps
| Study group | Role | What they receive |
|---|---|---|
| Duchenne Muscular Dystrophy | Children with Duchenne Muscular Dystrophy (DMD) between the ages of 7 and 16 who have been diagnosed with DMD as a result of genetic testing Receives: Other: Modified Mini Mental Test:; Other: The Controlled Oral Word Association Test; Other: The Central Nervous System Vital Signs; Other: Conners' Parent Rating Scale-48 (Parent Report); Other: Child Behavior Checklist 6-18 ages (Parent Report); Other: Strengths and Difficulties Questionnaire (Self-Reported); Other: Brooke Lower Extremity Functional Classification; Other: Motor Function Measurement-32 Items; Other: Four Square Step Test; Other: Six Minutes Walk Test; Other: Timed Performance Test | |
| Typically Developed Children | Typically Developed Children with similar physical characteristics between the ages of 7 and 16 Receives: Other: Modified Mini Mental Test:; Other: The Controlled Oral Word Association Test; Other: The Central Nervous System Vital Signs; Other: Conners' Parent Rating Scale-48 (Parent Report); Other: Child Behavior Checklist 6-18 ages (Parent Report); Other: Strengths and Difficulties Questionnaire (Self-Reported) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Modified Mini Mental Test
The Mini Mental Test developed for adults was adapted to the pediatric population by making minor modifications. Test; It evaluates verbal responses including attention, orientation, memory and language skills, ability to obey verbal and written orders, write spontaneous sentences, and copy a complex drawing. The highest score that can be obtained from this test is 35, the lowest score is 0.
Measured: only baseline
The Controlled Oral Word Association Test
This test requires the individual to name as many words as possible that begin with a given letter, i.e. K, A and S. Sixty seconds are allotted for each letter. Individuals cannot use proper names or numbers and cannot use words with different tenses or endings once the root word has been given
Measured: only baseline
The Central Nervous System Vital Signs
Central Nervous System Vital Signs is a reimbursable assessment procedure that utilizes computerized neuropsychological tests to evaluate the neurocognitive status of patients and covers a range of mental processes from simple motor performance, attention, memory, to executive functions.
Measured: only baseline
Conners' Parent Rating Scale-48 (Parent Report)
The Conners' Parent Rating Scale-48 contains 48 items wherein the frequency of each item is rated on a 4-point Likert scale ranging from not at all (0)-3 very much (3). The test has adequate psychometric properties and is widely used for clinical and research purposes with the attention deficit/hyperactivity disorder population
Measured: only baseline
Child Behavior Checklist 6-18 ages (Parent Report)
The Child Behavior Checklist/6-18 assesses both child adaptive behaviors and problem behaviors. There are 112 items that assess problem behaviors and 20 items that assess adaptive behavior. Response format for problem behaviors is from 0 ("not true") to 2 ("very true"). The problem behavior items load onto two broad-band scales (Internalizing and Externalizing) and eight narrow-band scales (Rule Breaking, Aggressive Behavior, Withdrawn-Depressed, Somatic Complaints, Anxious Depressed, Social Problems, Thought Problems, and Attention Problems). The adaptive behavior items load onto three scales: Activities, Social Competence, and School Competence. A Total Competence and Total Behavior Problems score are also provided.
Measured: only baseline
Strengths and Difficulties Questionnaire (Self-Reported)
The Strengths and Difficulties Questionnaire is a brief emotional and behavioural screening questionnaire for children and young people. The tool can capture the perspective of children. The 25 items in the test comprise 5 scales of 5 items each. The scales include: emotional symptoms subscale, conduct problems subscale, hyperactivity/inattention subscale, peer relationships problem subscale, prosocial behaviour subscale.
Measured: only baseline
Brooke Lower Extremity Functional Classification
It was developed using the classification method based on "Vignos et al." to determine the functional status of the lower extremity. It consists of 10 different levels, ranging from Level 1 (walks independently and climbs stairs) to Level 10 (bound to bed).
Measured: only baseline
Motor Function Measurement-32 Items
The Motor Function Measure is a scale designed for the assessment of motor function and progression of weakness in neuromuscular disorders. It is applicable to both ambulant and non-ambulant patients with a wide range of severity. The scale exists in two versions, one with 32 items for patients over 6 years of age (MFM-32), the other with 20 items for children aged from 2 to 6 years (MFM-20). Concerning the development of the scale, factor analysis identified three functional dimensions: D1 = standing position and transfers (13 items; 8 items in the short version), D2 = axial and proximal motor function (12 items; 8 in the short version), and D3 = distal motor function (7 items; 4 in the short version).
Measured: only baseline
Four Square Step Test
It is a valid and reliable test that has been used frequently in children in recent years to evaluate dynamic balance. Sticks, each 90 cm long, are placed on the floor to form 4 squares and the squares are numbered from 1 to 4. For the test to be completed successfully, the child must quickly move from one square to the next without touching the sticks. Performance is determined by measuring the test completion time in seconds. Shorter completion time means better dynamic balance.
Measured: only baseline
Six Minutes Walk Test
The 6-minutes walk test, which is valid and reliable for DMD patients, will evaluate the walking function and physical capacity of children at the submaximal level. The distance the child walks for 6 minutes in a 25 m corridor will be recorded in meters. A physiotherapist will walk with the children during the test and track the time with a stopwatch. The test is simple and considered an important outcome measure for children with DMD.
Measured: only baseline
10 meters Walk& Run Test
A 10-meter distance was marked on an unobstructed, flat surface using tape. To limit the impact of acceleration and deceleration on gait speed, start and finish lines were placed 30 centimeter before and after the 10-meter distance. Participants were instructed to begin with toes on the start line and walk or run as fast as possible, without compromising safety, to the finish line.
Measured: only baseline
Gower's(from a supine to a standing position)
Children lied down on a mat with straight position and asked them to stand up as fast as possible. Time was started when he moved and stopped when he was upright position.
Measured: only baseline
Right& Left Leg Standing Test
Children had to maintain a one-legged stance for as long as they could with their eyes open, and allowing them to freely-move their arms. Children were verbally encouraged to maintain the one-legged standing position for as long as possible during test.
Measured: only baseline
Ascent/Descent of 4 Steps
The children were asked to climb up the 4-step ladder with double-sided handrails as fast as possible. The time was started when his feet lifted from the ground and when both feet touched the ground, the time was stopped and recorded in seconds. After climbing the ladder, they were asked to descend as fast as possible, the time was started when the foot was lifted, and the time was stopped when both feet touched the ground and recorded in seconds.
Measured: only baseline
Secondary outcomes (1)
Genetic test report
The effect of the mutation region of dystrophin protein isoforms causing DMD on the neuropsychological profile of children will be investigated by comparing them with typically developed boys and the effect of this on motor function will be examined.
Measured: only baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2022
- Study start11 May 2022
- Primary completion1 Mar 2023 (estimated)
- Study completion1 Mar 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Duchenne Muscular DystrophyStudies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 74 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esra Aldırmaz, Hacettepe University
- Investigators
- İpek Gürbüz, Assc. Prof., Study director, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05661071
- Sponsor's protocol ID
- GO22/310
- Status last verified
- Dec 2022
- First submitted
- 4 Dec 2022
- Last updated
- 22 Dec 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Aldirmaz E, Bulut N, Yilmaz O, Alemdaroglu-Gurbuz I. Cognitive and emotional-behavioural outcomes of Turkish Duchenne muscular dystrophy population and its association with motor function. Eur J Paediatr Neurol. 2024 Sep;52:86-94. doi: 10.1016/j.ejpn.2024.08.004. Epub 2024 Aug 18.
PubMed 39180809
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determination of Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Investigation of Its Effects on Motor Functions
- ClinicalTrials.gov ID
- NCT05661071
- Acronym / sponsor ID
- GO22/310
- Conditions
- Duchenne Muscular Dystrophy
- Keywords
- Duchenne Muscular Dystrophy (DMD), neuropsychological profile, cognitive status, neurodevelopmental status, motor function, balance
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 74 participants (actual)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 11 May 2022 (actual)
- Primary completion
- 1 Mar 2023 (estimated)
- Study completion
- 1 Mar 2023 (estimated)
- First posted
- 22 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was planned to determine neuropsychological profiles of children with Duchenne Muscular Dystrophy and investigation of its effects on motor functions \& compare to typically developed peers.
Detailed description
In this thesis, it is aimed to determine the neuropsychological profiles of children with Duchenne Muscular Dystrophy (DMD) and to investigate its effects on motor functions. The study will be carried out with children between the ages of 7 and 16 who have been diagnosed with DMD as a result of genetic testing and who applied to Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Pediatric Neuromuscular Diseases Unit for physiotherapy and rehabilitation evaluation. In addition, considering the primary purpose of the study, typically developed boys between the ages of 7 and 16 with similar physical characteristics will be included in the study and compared with children with DMD. Typically developed boys included in the study will be evaluated only with neuropsychological tests. Evaluating cognitive function from neuropsychological tests; Modified Mini Mental Test, The Controlled Oral Word Association Test,computer-based The Central Nervous System Vital Signs will be applied. To evaluate neurodevelopmental status from neuropsychological tests; Conners' Parent Rating Scale, Child Behavior Checklist, Strengths and Difficulties Questionnaire (SDQ) will be applied. To evaluate the motor functions of individuals with DMD; Brooke Lower Extremity Functional Classification, Motor Function Measurement, Four Square Step Test, Six Minutes Walk Test, Timed Performance Tests (10 meters Walk/Run Test, Gower's (from a supine to a standing position), Right/Left Leg Standing, Ascent/Descent of 4 Steps) will be used. In the study, in which the effect of the mutation region of dystrophin protein isoforms causing DMD on the neuropsychological profile of children will be investigated by comparing them with typically developed boys and the effect of this on motor function will be examined, the statistical significance level will be considered as p<0.05
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Duchenne Muscular Dystrophy | – | Other: Modified Mini Mental Test:, Other: The Controlled Oral Word Association Test, Other: The Central Nervous System Vital Signs, Other: Conners' Parent Rating Scale-48 (Parent Report), Other: Child Behavior Checklist 6-18 ages (Parent Report), Other: Strengths and Difficulties Questionnaire (Self-Reported), Other: Brooke Lower Extremity Functional Classification, Other: Motor Function Measurement-32 Items, Other: Four Square Step Test, Other: Six Minutes Walk Test, Other: Timed Performance TestChildren with Duchenne Muscular Dystrophy (DMD) between the ages of 7 and 16 who have been diagnosed with DMD as a result of genetic testing |
| Typically Developed Children | – | Other: Modified Mini Mental Test:, Other: The Controlled Oral Word Association Test, Other: The Central Nervous System Vital Signs, Other: Conners' Parent Rating Scale-48 (Parent Report), Other: Child Behavior Checklist 6-18 ages (Parent Report), Other: Strengths and Difficulties Questionnaire (Self-Reported)Typically Developed Children with similar physical characteristics between the ages of 7 and 16 |
Who may qualify
- Ages
- 7 to 16 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Children with Duchenne Muscular Dystrophy
Key inclusion criteria (5 listed)
- Having been diagnosed with DMD by a pediatric neurologist,
- Being between the ages of 7-16,
- Not to have any diagnosed chronic disease,
- Not having lost yet the ability to write and draw as required by neuropsychological assessments,
- Cooperate with the physiotherapist and be able to comply with their instructions.
Key exclusion criteria (2 listed)
- Inability to cooperate adequately with the physiotherapist who made the evaluations,
- Have had any injury and/or surgery to the lower/upper extremities in the last 6 months, which may prevent the performance of motor function tests.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modified Mini Mental Test:To assess the cognitive function of children | Other | Duchenne Muscular Dystrophy, Typically Developed Children |
| The Controlled Oral Word Association TestTo assess the cognitive function of children | Other | Duchenne Muscular Dystrophy, Typically Developed Children |
| The Central Nervous System Vital SignsTo assess the cognitive function of children | Other | Duchenne Muscular Dystrophy, Typically Developed Children |
| Conners' Parent Rating Scale-48 (Parent Report)To assess attention-deficit/hyperactivity disorder | Other | Duchenne Muscular Dystrophy, Typically Developed Children |
| Child Behavior Checklist 6-18 ages (Parent Report)To assesses both child adaptive behaviors and problem behaviors. | Other | Duchenne Muscular Dystrophy, Typically Developed Children |
| Strengths and Difficulties Questionnaire (Self-Reported)It is a brief emotional and behavioural screening questionnaire for children and young people. | Other | Duchenne Muscular Dystrophy, Typically Developed Children |
| Brooke Lower Extremity Functional ClassificationTo determine the functional status of the lower extremity | Other | Duchenne Muscular Dystrophy |
| Motor Function Measurement-32 ItemsTo assessment of motor function and progression of weakness in neuromuscular disorders | Other | Duchenne Muscular Dystrophy |
| Four Square Step TestA test of dynamic balance and coordination that clinically assesses the participant's ability to step over objects forward, sideways, and backwards. | Other | Duchenne Muscular Dystrophy |
| Six Minutes Walk TestIt evaluates the walking function and physical capacity of children at the submaximal level. | Other | Duchenne Muscular Dystrophy |
| Timed Performance Test10 meters Walk\& Run Test, Gower's(from a supine to a standing position), Right\& Left Leg Standing, Ascent/Descent of 4 Steps | Other | Duchenne Muscular Dystrophy |
Primary outcome
Modified Mini Mental Test
Time frame: only baseline
The Mini Mental Test developed for adults was adapted to the pediatric population by making minor modifications. Test; It evaluates verbal responses including attention, orientation, memory and language skills, ability to obey verbal and written orders, write spontaneous sentences, and copy a complex drawing. The highest score that can be obtained from this test is 35, the lowest score is 0.
The Controlled Oral Word Association Test
Time frame: only baseline
This test requires the individual to name as many words as possible that begin with a given letter, i.e. K, A and S. Sixty seconds are allotted for each letter. Individuals cannot use proper names or numbers and cannot use words with different tenses or endings once the root word has been given
The Central Nervous System Vital Signs
Time frame: only baseline
Central Nervous System Vital Signs is a reimbursable assessment procedure that utilizes computerized neuropsychological tests to evaluate the neurocognitive status of patients and covers a range of mental processes from simple motor performance, attention, memory, to executive functions.
Conners' Parent Rating Scale-48 (Parent Report)
Time frame: only baseline
The Conners' Parent Rating Scale-48 contains 48 items wherein the frequency of each item is rated on a 4-point Likert scale ranging from not at all (0)-3 very much (3). The test has adequate psychometric properties and is widely used for clinical and research purposes with the attention deficit/hyperactivity disorder population
Child Behavior Checklist 6-18 ages (Parent Report)
Time frame: only baseline
The Child Behavior Checklist/6-18 assesses both child adaptive behaviors and problem behaviors. There are 112 items that assess problem behaviors and 20 items that assess adaptive behavior. Response format for problem behaviors is from 0 ("not true") to 2 ("very true"). The problem behavior items load onto two broad-band scales (Internalizing and Externalizing) and eight narrow-band scales (Rule Breaking, Aggressive Behavior, Withdrawn-Depressed, Somatic Complaints, Anxious Depressed, Social Problems, Thought Problems, and Attention Problems). The adaptive behavior items load onto three scales: Activities, Social Competence, and School Competence. A Total Competence and Total Behavior Problems score are also provided.
Strengths and Difficulties Questionnaire (Self-Reported)
Time frame: only baseline
The Strengths and Difficulties Questionnaire is a brief emotional and behavioural screening questionnaire for children and young people. The tool can capture the perspective of children. The 25 items in the test comprise 5 scales of 5 items each. The scales include: emotional symptoms subscale, conduct problems subscale, hyperactivity/inattention subscale, peer relationships problem subscale, prosocial behaviour subscale.
Brooke Lower Extremity Functional Classification
Time frame: only baseline
It was developed using the classification method based on "Vignos et al." to determine the functional status of the lower extremity. It consists of 10 different levels, ranging from Level 1 (walks independently and climbs stairs) to Level 10 (bound to bed).
Motor Function Measurement-32 Items
Time frame: only baseline
The Motor Function Measure is a scale designed for the assessment of motor function and progression of weakness in neuromuscular disorders. It is applicable to both ambulant and non-ambulant patients with a wide range of severity. The scale exists in two versions, one with 32 items for patients over 6 years of age (MFM-32), the other with 20 items for children aged from 2 to 6 years (MFM-20). Concerning the development of the scale, factor analysis identified three functional dimensions: D1 = standing position and transfers (13 items; 8 items in the short version), D2 = axial and proximal motor function (12 items; 8 in the short version), and D3 = distal motor function (7 items; 4 in the short version).
Four Square Step Test
Time frame: only baseline
It is a valid and reliable test that has been used frequently in children in recent years to evaluate dynamic balance. Sticks, each 90 cm long, are placed on the floor to form 4 squares and the squares are numbered from 1 to 4. For the test to be completed successfully, the child must quickly move from one square to the next without touching the sticks. Performance is determined by measuring the test completion time in seconds. Shorter completion time means better dynamic balance.
Six Minutes Walk Test
Time frame: only baseline
The 6-minutes walk test, which is valid and reliable for DMD patients, will evaluate the walking function and physical capacity of children at the submaximal level. The distance the child walks for 6 minutes in a 25 m corridor will be recorded in meters. A physiotherapist will walk with the children during the test and track the time with a stopwatch. The test is simple and considered an important outcome measure for children with DMD.
10 meters Walk& Run Test
Time frame: only baseline
A 10-meter distance was marked on an unobstructed, flat surface using tape. To limit the impact of acceleration and deceleration on gait speed, start and finish lines were placed 30 centimeter before and after the 10-meter distance. Participants were instructed to begin with toes on the start line and walk or run as fast as possible, without compromising safety, to the finish line.
Gower's(from a supine to a standing position)
Time frame: only baseline
Children lied down on a mat with straight position and asked them to stand up as fast as possible. Time was started when he moved and stopped when he was upright position.
Right& Left Leg Standing Test
Time frame: only baseline
Children had to maintain a one-legged stance for as long as they could with their eyes open, and allowing them to freely-move their arms. Children were verbally encouraged to maintain the one-legged standing position for as long as possible during test.
Ascent/Descent of 4 Steps
Time frame: only baseline
The children were asked to climb up the 4-step ladder with double-sided handrails as fast as possible. The time was started when his feet lifted from the ground and when both feet touched the ground, the time was stopped and recorded in seconds. After climbing the ladder, they were asked to descend as fast as possible, the time was started when the foot was lifted, and the time was stopped when both feet touched the ground and recorded in seconds.
1 secondary outcome
Genetic test report
Time frame: only baseline
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2022.
- Derived from this study: PubMed 39180809Aldirmaz E, Bulut N, Yilmaz O, Alemdaroglu-Gurbuz I. Cognitive and emotional-behavioural outcomes of Turkish Duchenne muscular dystrophy population and its association with motor function. Eur J Paediatr Neurol. 2024 Sep;52:86-94. doi: 10.1016/j.ejpn.2024.08.004. Epub 2024 Aug 18.
Related trials for Duchenne Muscular Dystrophy
RecruitingEarly Phase 1
Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients
Duchenne Muscular Dystrophy (DMD)
RecruitingPhase 2
Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Not yet recruitingPhase 2
A Phase 2 Trial to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tegacorat in Male Participants 4 to <7 Years of Age With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD)
Not yet recruitingObservational study
Multimodal Study About Absence of Dp140 in Becker Muscular Dystrophy: Brain-muscle Imaging, Cognition and Muscle Function
Becker Muscular Dystrophy
Enrolling by invitationObservational study
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice
Duchenne Muscular Dystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
İpek Gürbüz, Assc. Prof. study director
Hacettepe University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Duchenne Muscular Dystrophy, run by Hacettepe University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Modified Mini Mental Test (time frame: only baseline). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05661071, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2022.